Your browser doesn't support javascript.
loading
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Pe, Madeline; Alanya, Ahu; Falk, Ragnhild Sorum; Amdal, Cecilie Delphin; Bjordal, Kristin; Chang, Jane; Cislo, Paul; Coens, Corneel; Dirven, Linda; Speck, Rebecca M; Fitzgerald, Kristina; Galinsky, Jayne; Giesinger, Johannes M; Holzner, Bernhard; Le Cessie, Saskia; O'Connor, Daniel; Oliver, Kathy; Pawar, Vivek; Quinten, Chantal; Schlichting, Michael; Ren, Jinma; Roychoudhury, Satrajit; Taphoorn, Martin J B; Velikova, Galina; Wintner, Lisa M; Griebsch, Ingolf; Bottomley, Andrew.
Afiliación
  • Pe M; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium. Electronic address: madeline.pe@eortc.org.
  • Alanya A; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Falk RS; Research Support Services, Oslo University Hospital, Oslo, Norway.
  • Amdal CD; Research Support Services, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Bjordal K; Research Support Services, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Chang J; Pfizer, New York, NY, USA.
  • Cislo P; Pfizer, New York, NY, USA.
  • Coens C; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.
  • Speck RM; Critical Path Institute (C-Path), Tucson, AZ, USA.
  • Fitzgerald K; AbbVie, Mettawa, IL, USA.
  • Galinsky J; Myeloma Patients Europe, Brussels, Belgium.
  • Giesinger JM; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Holzner B; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Le Cessie S; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands; Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium.
  • O'Connor D; Medicines and Healthcare Products Regulatory Agency, London, UK.
  • Oliver K; International Brain Tumour Alliance, Surrey, UK.
  • Pawar V; EMD Serono, Billerica, MA, USA.
  • Quinten C; European Medicines Agency, Amsterdam, Netherlands.
  • Schlichting M; Merck, Healthcare KGaA, Darmstadt, Germany.
  • Ren J; Pfizer, New York, NY, USA.
  • Roychoudhury S; Pfizer, New York, NY, USA.
  • Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.
  • Velikova G; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, UK.
  • Wintner LM; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Griebsch I; Boehringer Ingelheim, Ingelheim am Rhein, Germany.
  • Bottomley A; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
Lancet Oncol ; 24(6): e270-e283, 2023 06.
Article en En | MEDLINE | ID: mdl-37269858

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
...